Global Human Injection Flu Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Human Injection Flu Vaccine market size was valued at US$ 7468.9 million in 2023. With growing demand in downstream market, the Human Injection Flu Vaccine is forecast to a readjusted size of US$ 10860 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Human Injection Flu Vaccine market. Human Injection Flu Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Injection Flu Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Injection Flu Vaccine market.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Human Injection Flu Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Injection Flu Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Injection Flu Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Injection Flu Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Injection Flu Vaccine industry. This include advancements in Human Injection Flu Vaccine technology, Human Injection Flu Vaccine new entrants, Human Injection Flu Vaccine new investment, and other innovations that are shaping the future of Human Injection Flu Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Injection Flu Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Human Injection Flu Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Injection Flu Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Injection Flu Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Injection Flu Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Injection Flu Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Injection Flu Vaccine market.
Market Segmentation:
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Human Injection Flu Vaccine market?
What factors are driving Human Injection Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Injection Flu Vaccine market opportunities vary by end market size?
How does Human Injection Flu Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Human Injection Flu Vaccine market size was valued at US$ 7468.9 million in 2023. With growing demand in downstream market, the Human Injection Flu Vaccine is forecast to a readjusted size of US$ 10860 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Human Injection Flu Vaccine market. Human Injection Flu Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Injection Flu Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Injection Flu Vaccine market.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Human Injection Flu Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Injection Flu Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Injection Flu Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Injection Flu Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Injection Flu Vaccine industry. This include advancements in Human Injection Flu Vaccine technology, Human Injection Flu Vaccine new entrants, Human Injection Flu Vaccine new investment, and other innovations that are shaping the future of Human Injection Flu Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Injection Flu Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Human Injection Flu Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Injection Flu Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Injection Flu Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Injection Flu Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Injection Flu Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Injection Flu Vaccine market.
Market Segmentation:
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Jiangsu GDK
- KM Biologics
What is the 10-year outlook for the global Human Injection Flu Vaccine market?
What factors are driving Human Injection Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Injection Flu Vaccine market opportunities vary by end market size?
How does Human Injection Flu Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Injection Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Injection Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Injection Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Human Injection Flu Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Human Injection Flu Vaccine Sales by Type
2.3.1 Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Human Injection Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Injection Flu Vaccine Sale Price by Type (2019-2024)
2.4 Human Injection Flu Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Human Injection Flu Vaccine Sales by Application
2.5.1 Global Human Injection Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Human Injection Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Injection Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL HUMAN INJECTION FLU VACCINE BY COMPANY
3.1 Global Human Injection Flu Vaccine Breakdown Data by Company
3.1.1 Global Human Injection Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Human Injection Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Human Injection Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Human Injection Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global Human Injection Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Human Injection Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Injection Flu Vaccine Product Location Distribution
3.4.2 Players Human Injection Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN INJECTION FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Injection Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Injection Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Injection Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Injection Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Human Injection Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Injection Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Injection Flu Vaccine Sales Growth
4.4 APAC Human Injection Flu Vaccine Sales Growth
4.5 Europe Human Injection Flu Vaccine Sales Growth
4.6 Middle East & Africa Human Injection Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Injection Flu Vaccine Sales by Country
5.1.1 Americas Human Injection Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas Human Injection Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas Human Injection Flu Vaccine Sales by Type
5.3 Americas Human Injection Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Injection Flu Vaccine Sales by Region
6.1.1 APAC Human Injection Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC Human Injection Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC Human Injection Flu Vaccine Sales by Type
6.3 APAC Human Injection Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Injection Flu Vaccine by Country
7.1.1 Europe Human Injection Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe Human Injection Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe Human Injection Flu Vaccine Sales by Type
7.3 Europe Human Injection Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Injection Flu Vaccine by Country
8.1.1 Middle East & Africa Human Injection Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Injection Flu Vaccine Sales by Type
8.3 Middle East & Africa Human Injection Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine
10.3 Manufacturing Process Analysis of Human Injection Flu Vaccine
10.4 Industry Chain Structure of Human Injection Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Injection Flu Vaccine Distributors
11.3 Human Injection Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN INJECTION FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Injection Flu Vaccine Market Size Forecast by Region
12.1.1 Global Human Injection Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global Human Injection Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Injection Flu Vaccine Forecast by Type
12.7 Global Human Injection Flu Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Human Injection Flu Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Injection Flu Vaccine Product Portfolios and Specifications
13.2.3 CSL Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Human Injection Flu Vaccine Product Portfolios and Specifications
13.3.3 GSK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Human Injection Flu Vaccine Product Portfolios and Specifications
13.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Human Injection Flu Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Human Injection Flu Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Human Injection Flu Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Human Injection Flu Vaccine Product Portfolios and Specifications
13.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Human Injection Flu Vaccine Product Portfolios and Specifications
13.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Injection Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Injection Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Injection Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Human Injection Flu Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Human Injection Flu Vaccine Sales by Type
2.3.1 Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Human Injection Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Injection Flu Vaccine Sale Price by Type (2019-2024)
2.4 Human Injection Flu Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Human Injection Flu Vaccine Sales by Application
2.5.1 Global Human Injection Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Human Injection Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Injection Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL HUMAN INJECTION FLU VACCINE BY COMPANY
3.1 Global Human Injection Flu Vaccine Breakdown Data by Company
3.1.1 Global Human Injection Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Human Injection Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Human Injection Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Human Injection Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global Human Injection Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Human Injection Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Injection Flu Vaccine Product Location Distribution
3.4.2 Players Human Injection Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN INJECTION FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Injection Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Injection Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Injection Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Injection Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Human Injection Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Injection Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Injection Flu Vaccine Sales Growth
4.4 APAC Human Injection Flu Vaccine Sales Growth
4.5 Europe Human Injection Flu Vaccine Sales Growth
4.6 Middle East & Africa Human Injection Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Injection Flu Vaccine Sales by Country
5.1.1 Americas Human Injection Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas Human Injection Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas Human Injection Flu Vaccine Sales by Type
5.3 Americas Human Injection Flu Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Injection Flu Vaccine Sales by Region
6.1.1 APAC Human Injection Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC Human Injection Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC Human Injection Flu Vaccine Sales by Type
6.3 APAC Human Injection Flu Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Injection Flu Vaccine by Country
7.1.1 Europe Human Injection Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe Human Injection Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe Human Injection Flu Vaccine Sales by Type
7.3 Europe Human Injection Flu Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Injection Flu Vaccine by Country
8.1.1 Middle East & Africa Human Injection Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Injection Flu Vaccine Sales by Type
8.3 Middle East & Africa Human Injection Flu Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine
10.3 Manufacturing Process Analysis of Human Injection Flu Vaccine
10.4 Industry Chain Structure of Human Injection Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Injection Flu Vaccine Distributors
11.3 Human Injection Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN INJECTION FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Injection Flu Vaccine Market Size Forecast by Region
12.1.1 Global Human Injection Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global Human Injection Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Injection Flu Vaccine Forecast by Type
12.7 Global Human Injection Flu Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Human Injection Flu Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Injection Flu Vaccine Product Portfolios and Specifications
13.2.3 CSL Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Human Injection Flu Vaccine Product Portfolios and Specifications
13.3.3 GSK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Human Injection Flu Vaccine Product Portfolios and Specifications
13.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Human Injection Flu Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Human Injection Flu Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Human Injection Flu Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Human Injection Flu Vaccine Product Portfolios and Specifications
13.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Human Injection Flu Vaccine Product Portfolios and Specifications
13.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Injection Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Injection Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Human Injection Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Human Injection Flu Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Human Injection Flu Vaccine Revenue by Application (2019-2024)
Table 13. Global Human Injection Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Human Injection Flu Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Human Injection Flu Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Human Injection Flu Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Human Injection Flu Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Human Injection Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Human Injection Flu Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Injection Flu Vaccine Products Offered
Table 22. Human Injection Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Injection Flu Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Human Injection Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Human Injection Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Human Injection Flu Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Human Injection Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Human Injection Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Human Injection Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Human Injection Flu Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Human Injection Flu Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Human Injection Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Injection Flu Vaccine
Table 58. Key Market Challenges & Risks of Human Injection Flu Vaccine
Table 59. Key Industry Trends of Human Injection Flu Vaccine
Table 60. Human Injection Flu Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Injection Flu Vaccine Distributors List
Table 63. Human Injection Flu Vaccine Customer List
Table 64. Global Human Injection Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Human Injection Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Human Injection Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Human Injection Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Human Injection Flu Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Human Injection Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Human Injection Flu Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Human Injection Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Human Injection Flu Vaccine Product Portfolios and Specifications
Table 80. Sanofi Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Human Injection Flu Vaccine Product Portfolios and Specifications
Table 85. CSL Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Human Injection Flu Vaccine Product Portfolios and Specifications
Table 90. GSK Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Human Injection Flu Vaccine Product Portfolios and Specifications
Table 95. Viatris Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Human Injection Flu Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Human Injection Flu Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Human Injection Flu Vaccine Product Portfolios and Specifications
Table 115. Sinovac Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. Jiangsu GDK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu GDK Human Injection Flu Vaccine Product Portfolios and Specifications
Table 120. Jiangsu GDK Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Jiangsu GDK Main Business
Table 122. Jiangsu GDK Latest Developments
Table 123. KM Biologics Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. KM Biologics Human Injection Flu Vaccine Product Portfolios and Specifications
Table 125. KM Biologics Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. KM Biologics Main Business
Table 127. KM Biologics Latest Developments
Table 1. Human Injection Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Injection Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Human Injection Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Human Injection Flu Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Human Injection Flu Vaccine Revenue by Application (2019-2024)
Table 13. Global Human Injection Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Human Injection Flu Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Human Injection Flu Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Human Injection Flu Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Human Injection Flu Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Human Injection Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Human Injection Flu Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Injection Flu Vaccine Products Offered
Table 22. Human Injection Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Injection Flu Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Human Injection Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Human Injection Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Human Injection Flu Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Human Injection Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Human Injection Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Human Injection Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Human Injection Flu Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Human Injection Flu Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Human Injection Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Human Injection Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Human Injection Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Human Injection Flu Vaccine
Table 58. Key Market Challenges & Risks of Human Injection Flu Vaccine
Table 59. Key Industry Trends of Human Injection Flu Vaccine
Table 60. Human Injection Flu Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Human Injection Flu Vaccine Distributors List
Table 63. Human Injection Flu Vaccine Customer List
Table 64. Global Human Injection Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Human Injection Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Human Injection Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Human Injection Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Human Injection Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Human Injection Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Human Injection Flu Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Human Injection Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Human Injection Flu Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Human Injection Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Human Injection Flu Vaccine Product Portfolios and Specifications
Table 80. Sanofi Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Human Injection Flu Vaccine Product Portfolios and Specifications
Table 85. CSL Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Human Injection Flu Vaccine Product Portfolios and Specifications
Table 90. GSK Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Human Injection Flu Vaccine Product Portfolios and Specifications
Table 95. Viatris Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Human Injection Flu Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Human Injection Flu Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Human Injection Flu Vaccine Product Portfolios and Specifications
Table 115. Sinovac Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. Jiangsu GDK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu GDK Human Injection Flu Vaccine Product Portfolios and Specifications
Table 120. Jiangsu GDK Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Jiangsu GDK Main Business
Table 122. Jiangsu GDK Latest Developments
Table 123. KM Biologics Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. KM Biologics Human Injection Flu Vaccine Product Portfolios and Specifications
Table 125. KM Biologics Human Injection Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. KM Biologics Main Business
Table 127. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Injection Flu Vaccine
Figure 2. Human Injection Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Injection Flu Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Human Injection Flu Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Injection Flu Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Human Injection Flu Vaccine Sales Market Share by Type in 2023
Figure 12. Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Human Injection Flu Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Human Injection Flu Vaccine Market: 6 Months to 3 Years (2019-2024) & (K Units)
Figure 15. Human Injection Flu Vaccine Consumed in > 3 Years
Figure 16. Global Human Injection Flu Vaccine Market: > 3 Years (2019-2024) & (K Units)
Figure 17. Global Human Injection Flu Vaccine Sales Market Share by Application (2023)
Figure 18. Global Human Injection Flu Vaccine Revenue Market Share by Application in 2023
Figure 19. Human Injection Flu Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Human Injection Flu Vaccine Sales Market Share by Company in 2023
Figure 21. Human Injection Flu Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Human Injection Flu Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Human Injection Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Human Injection Flu Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Human Injection Flu Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 72. Industry Chain Structure of Human Injection Flu Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Human Injection Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Human Injection Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Human Injection Flu Vaccine
Figure 2. Human Injection Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Injection Flu Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Human Injection Flu Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Injection Flu Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Human Injection Flu Vaccine Sales Market Share by Type in 2023
Figure 12. Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Human Injection Flu Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Human Injection Flu Vaccine Market: 6 Months to 3 Years (2019-2024) & (K Units)
Figure 15. Human Injection Flu Vaccine Consumed in > 3 Years
Figure 16. Global Human Injection Flu Vaccine Market: > 3 Years (2019-2024) & (K Units)
Figure 17. Global Human Injection Flu Vaccine Sales Market Share by Application (2023)
Figure 18. Global Human Injection Flu Vaccine Revenue Market Share by Application in 2023
Figure 19. Human Injection Flu Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Human Injection Flu Vaccine Sales Market Share by Company in 2023
Figure 21. Human Injection Flu Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Human Injection Flu Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Human Injection Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Human Injection Flu Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Human Injection Flu Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Human Injection Flu Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Human Injection Flu Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Human Injection Flu Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 72. Industry Chain Structure of Human Injection Flu Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Human Injection Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Human Injection Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
